A case for developing antiviral drugs against polio
- 30 September 2008
- journal article
- review article
- Published by Elsevier BV in Antiviral Research
- Vol. 79 (3), 179-187
- https://doi.org/10.1016/j.antiviral.2008.04.002
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- NIAID resources for developing new therapies for severe viral infectionsAntiviral Research, 2008
- Potential Use of Antiviral Agents in Polio EradicationEmerging Infectious Diseases, 2008
- In Vitro Resistance Study of Rupintrivir, a Novel Inhibitor of Human Rhinovirus 3C ProteaseAntimicrobial Agents and Chemotherapy, 2007
- Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistanceGenes & Development, 2007
- Vaccine-derived poliovirus from long term excretors and the end game of polio eradicationBiologicals, 2006
- A Dynamic Model of Poliomyelitis Outbreaks: Learning from the Past to Help Inform the FutureAmerican Journal of Epidemiology, 2005
- Immune responses and the emergence of drug–resistant virus strainsin vivoProceedings. Biological sciences, 2004
- Antipicornavirus activity of SCH 47802 and analogs: in vitro and in vivo studiesAntiviral Research, 1996
- Studies of rhinovirus resistant to an antiviral chalconeAntiviral Research, 1987
- Antiviral Effect of GuanidineScience, 1961